SFX by Ex Libris Inc.

Title:	Structural basis of immune evasion at the site of CD4 attachment on HIV-1 gp120
Source:	Science [0036-8075] Chen, L yr:2009

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Wyatt, Richard T T. "HIV vaccine design and the neutralizing antibody problem." Nature immunology 5.3 (2004): 233-6.
description	2.	Xie, H. "Structure-Activity Relationships in the Binding of Chemically Derivatized CD4 to gp120 from Human Immunodeficiency Virus." Journal of medicinal chemistry 50.20 (2007): 4898-908.
description	3.	Finzi, D. "Defining and solving the essential protein-protein interactions in HIV infection." Journal of structural biology 158.2 (2006): 148-155.
description	4.	Huang, B. "TLR signaling by tumor and immune cells: a double-edged sword." Oncogene 27.2 (2007): 218-24.
description	5.	Binley, James M M. "Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies." Journal of virology 78.23 (2005): 13232-52.
description	6.	Wyatt, R. "The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens." Science 280.5371 (1998): 1884-8.
description	7.	Wei, George M M. "Antibody neutralization and escape by HIV-1." Nature 422.6929 (2003): 307-312.
description	8.	KOFF, W. "HIV vaccine development: Challenges and opportunities towards solving the HIV vaccine-neutralizing antibody problem." Vaccine 30.29 (2011): 4310-4315.
description	9.	Fauci, Anthony S. "HIV vaccine research: the way forward." Science 321.5888 (2008): 530-532.
description	10.	McMichael, A. "HIV VACCINES." Annual review of immunology 24.1 (2006): 227-255.
description	11.	Mikuni, J. "A fluorescence correlation spectroscopy-based assay for fragment screening of slowly inhibiting protein-peptide interaction inhibitors." Analytical biochemistry 402.1 (2010): 26-31.
description	12.	Lin, Pin-Fang F. "A small molecule HIV-1 inhibitor that targets the HIV-1 envelope and inhibits CD4 receptor binding." Proceedings of the National Academy of Sciences of the United States of America 100.19 (2003): 11013-11018.
description	13.	Sattentau, Q J J. "The neutralizing antibody response to HIV-1: viral evasion and escape from humoral immunity." AIDS 13.sA (1999): 137-62.
description	14.	Posner, Marshall R R. "Interactions of human antibodies, epitope exposure, antibody binding and neutralization of primary isolate HIV-1 virions." AIDS 16.18 (2003): 2409-2417.
description	15.	Kuhn, P. "The genesis of high-throughput structure-based drug discovery using protein crystallography." Current opinion in chemical biology 6.5 (2002): 704-710.
description	16.	Killeen, S D D. "Exploitation of the Toll-like receptor system in cancer: a doubled-edged sword?" The British journal of cancer 95.3 (2006): 247-52.
description	17.	Zitvogel, L. "Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy." Nature medicine 13.9 (2007): 1050-9.
description	18.	Saïb, A. "Early stages of HIV replication: how to hijack cellular functions for a successful infection." AIDS reviews 6.4 (2004): 199-207.
description	19.	O'Neill, Luke A J A. "When signaling pathways collide: positive and negative regulation of toll-like receptor signal transduction." Immunity 29.1 (2008): 12-20.
description	20.	Smyth, M J J. "A fresh look at tumor immunosurveillance and immunotherapy." Nature immunology 2.4 (2001): 293-9.